Novartis gives H1N1 vaccine supply update

Novartis AG (NYSE:NVS; SIX:NOVN) said it has shipped more than 7.5 million doses of its unadjuvanted swine influenza A (H1N1) vaccine in the U.S. and expects to reach a total of 25-30 million doses by the end of November. Novartis said it is on track to produce 90 million units of bulk antigen, which is in line with its commitment to HHS and is expected to yield 60 million vaccine doses. ...